These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 26274912)

  • 1. Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis.
    Katsanos K; Spiliopoulos S; Saha P; Diamantopoulos A; Karunanithy N; Krokidis M; Modarai B; Karnabatidis D
    PLoS One; 2015; 10(8):e0135692. PubMed ID: 26274912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis.
    De Carlo M; Di Minno G; Sayre T; Fazeli MS; Siliman G; Cimminiello C
    Curr Vasc Pharmacol; 2021; 19(5):542-555. PubMed ID: 32819249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.
    Squizzato A; Bellesini M; Takeda A; Middeldorp S; Donadini MP
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD005158. PubMed ID: 29240976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet agents for intermittent claudication.
    Wong PF; Chong LY; Mikhailidis DP; Robless P; Stansby G
    Cochrane Database Syst Rev; 2011 Nov; (11):CD001272. PubMed ID: 22071801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis.
    Willems LH; Maas DPMSM; Kramers K; Reijnen MMPJ; Riksen NP; Ten Cate H; van der Vijver-Coppen RJ; de Borst GJ; Mees BME; Zeebregts CJ; Hannink G; Warlé MC
    Drugs; 2022 Aug; 82(12):1287-1302. PubMed ID: 35997941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC; Dwivedi G
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD003186. PubMed ID: 22161375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
    Robertson L; Ghouri MA; Kovacs F
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002071. PubMed ID: 22895926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
    Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
    Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison efficacy and safety of different antiplatelet or anticoagulation drugs in chronic coronary syndromes patients: A Bayesian network meta-analysis.
    Liu C; Ma L
    Medicine (Baltimore); 2023 Dec; 102(48):e36429. PubMed ID: 38050293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials.
    Galli M; Capodanno D; Benenati S; D'Amario D; Crea F; Andreotti F; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):519-528. PubMed ID: 34146091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monotherapy with a P2Y
    Chiarito M; Sanz-Sánchez J; Cannata F; Cao D; Sturla M; Panico C; Godino C; Regazzoli D; Reimers B; De Caterina R; Condorelli G; Ferrante G; Stefanini GG
    Lancet; 2020 May; 395(10235):1487-1495. PubMed ID: 32386592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial.
    Biagioni RB; Lopes RD; Agati LB; Sacilotto R; Wolosker N; Sobreira ML; de Freitas Soares BL; Joviliano EE; Bernardi WH; Junior VC; Caffaro RA; Fioranelli A; Van Bellen B; Casella IB; Fidelis RJR; Flumignan RLG; Comerota AJ; Ramacciotti E
    Am Heart J; 2020 Sep; 227():100-106. PubMed ID: 32730905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.
    Malloy RJ; Kanaan AO; Silva MA; Donovan JL
    Clin Ther; 2013 Oct; 35(10):1490-1500.e7. PubMed ID: 24139421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
    Antithrombotic Trialists' Collaboration
    BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel Vs Aspirin Monotherapy Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Tan BE; Wong PY; Baibhav B; Thakkar S; Azhar AZ; Rao M; Cheung JW
    Curr Probl Cardiol; 2023 Aug; 48(8):101174. PubMed ID: 35341798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis.
    Zheng N; Zhong J; Chen X; Su J; Liu C; Jiang L
    Am J Cardiovasc Drugs; 2023 May; 23(3):257-267. PubMed ID: 36867384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
    Rymer J; Anand SS; Sebastian Debus E; Haskell LP; Hess CN; Jones WS; Muehlhofer E; Berkowitz SD; Bauersachs RM; Bonaca MP; Patel MR
    Circulation; 2023 Dec; 148(24):1919-1928. PubMed ID: 37850397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
    JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.